l 778,123 has been researched along with Leukemia, Myeloid in 2 studies
*Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dallmann, I; Ganser, A; Morgan, MA; Onono, FO; Reuter, CW; Scherr, M; Spielmann, HP; Subramanian, T; Venturini, L | 1 |
| Huang, XK; Li, B; Meyer, P; Preisler, HD; Raza, A | 1 |
2 other study(ies) available for l 778,123 and Leukemia, Myeloid
| Article | Year |
|---|---|
Modulation of anthracycline-induced cytotoxicity by targeting the prenylated proteome in myeloid leukemia cells.
Topics: Anthracyclines; Antigens, Neoplasm; Apoptosis; Benzodiazepines; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dimethylallyltranstransferase; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Synergism; Farnesyltranstransferase; Gene Expression Regulation, Neoplastic; Humans; Idarubicin; Imidazoles; Leukemia, Myeloid; MAP Kinase Signaling System; Poly-ADP-Ribose Binding Proteins; Protein Prenylation | 2012 |
The effects of the farnesyl transferase inhibitor FTI L-778,123 on normal, myelodysplastic, and myeloid leukemia bone marrow progenitor proliferation in vitro.
Topics: Alkyl and Aryl Transferases; Antineoplastic Agents; Bone Marrow Cells; Case-Control Studies; Cell Division; Dose-Response Relationship, Drug; Enzyme Inhibitors; Farnesyltranstransferase; Humans; Imidazoles; Leukemia, Myeloid; Myelodysplastic Syndromes; Neoplastic Stem Cells | 2003 |